Bromazepam

MECHANISM OF ACTION

Bromazepam is a benzodiazepine that works by enhancing the action of GABA, a natural inhibitory neurotransmitter in the brain. By binding to GABA-A receptors, it increases chloride ion flow into neurons, calming overactive nerve activity and producing anxiety relief, sedation, and muscle relaxation.

PHARMACOKINETICS

Absorption

Bromazepam is well absorbed orally, with peak blood levels usually reached within 1 to 3 hours after ingestion. Its absorption is generally unaffected by food, and it has good bioavailability, allowing it to effectively enter the bloodstream and act on the central nervous system

Distribution

Bromazepam has a volume of distribution (Vd) of approximately 1.1–3.5 L/kg in adults. This indicates it distributes moderately into body tissues, including the brain, where it exerts its therapeutic effects.

Metabolism

Bromazepam is metabolized in the liver through oxidation and hydroxylation, producing mostly inactive metabolites. Its breakdown depends on liver function, so doses may need adjustment in patients with impaired hepatic activity.

Excretion

Bromazepam is primarily excreted through the urine as inactive metabolites. A small amount may be eliminated unchanged. Its elimination is relatively slow, with a half-life of 10–20 hours, which allows for once- or twice-daily dosing.

PHARMACODYNAMICS

Bromazepam is a benzodiazepine that produces anxiolytic, sedative, muscle-relaxant, andanticonvulsant effects by enhancing the action of GABA at GABA-A receptors in the central nervous system. This increases neuronal inhibition, reducing overactive nerve signaling and calming anxiety, tension, and related symptoms.

ADMINISTRATION

Bromazepam is administered orally, usually in tablet form. It is typically taken 1–3 times daily depending on the severity of symptoms and the prescribed dose. The tablets should be swallowed with water, and dosing should follow a physician’s guidance to minimize the risk of sedation, dependence, or tolerance.

DOSAGE AND STRENGTH

Bromazepam is available in tablet strengths of 1.5 mg, 3 mg, and 6 mg.

• Typical adult dosage for anxiety: 3–6 mg 2–3 times daily, adjusted based on severity and patient response.

• Elderly or debilitated patients: Lower doses are recommended, often starting at 1.5 mg 2–3 times daily, to reduce the risk of sedation and falls.

FOOD INTERACTIONS

Bromazepam has minimal food interactions. However, combining bromazepam with alcohol or other CNS depressants can greatly increase sedation, drowsiness, and risk of respiratory depression, so such combinations should be avoided.

DRUG INTERACTIONS

Bromazepam can interact with alcohol, other CNS depressants, certain antidepressants, and drugs affecting liver enzymes, which may increase sedation or alter its levels. Caution and dose adjustments are recommended when combining it with these medications.

CONTRAINDICATIONS

Bromazepam is contraindicated in patients with severe respiratory insufficiency, acutepulmonary disease, sleep apnea, or severe liver impairment. It should also be avoided in individuals with myasthenia gravis, severe kidney disease, or known hypersensitivity to benzodiazepines, and during pregnancy and breastfeeding due to potential harm to the fetus or infant.

SIDE EFFECTS

• Drowsiness

• Dizziness

• Fatigue

• Impaired coordination

• Confusion

• Memory problems

• Headache

• Nausea

• Blurred vision

• Agitation

• Irritability

• Aggression

OVERDOSE

1. Seek immediate medical help – Call emergency services or go to the nearest hospital right away.

2. Do not induce vomiting unless instructed by a healthcare professional.

3. Keep the person awake and breathing – Monitor their breathing and responsiveness.

4. Avoid giving food, drink, or alcohol.

TOXICITY

Bromazepam has moderate toxicity, causing central nervous system depression at high doses, including severe sedation and impaired breathing. While less dangerous alone, its toxicity increases significantly when combined with alcohol or other CNS depressants, and prolonged use may lead to dependence.